anidulafungin has been researched along with Hematologic Malignancies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
| Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X | 1 |
| Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL | 1 |
| Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR | 1 |
| Cotton, D | 1 |
| Ruiz Camps, I; Vázquez López, L | 1 |
| Green, MR; Greene, JN; Wetzstein, GA | 1 |
1 review(s) available for anidulafungin and Hematologic Malignancies
| Article | Year |
|---|---|
[Potential of anidulafungin in hematological patients].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors | 2008 |
3 trial(s) available for anidulafungin and Hematologic Malignancies
| Article | Year |
|---|---|
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole | 2019 |
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2019 |
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult | 2015 |
3 other study(ies) available for anidulafungin and Hematologic Malignancies
| Article | Year |
|---|---|
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Celebrating the ACP centennial: from the annals archive.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Voriconazole | 2015 |
Mould breakthrough in immunosuppressed adults receiving anidulafungin: a report of 2 cases.
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Echinocandins; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Superinfection | 2007 |